Citation Impact
46 standout
Citing Papers
The communication mechanism of the gut-brain axis and its effect on central nervous system diseases: A systematic review
2024 Standout
NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer
2024 Standout
Works of Yan Moore being referenced
First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study
2021
First-in-human biomarker-driven phase I trial of the potent and selective glutaminase-1 (GLS1) inhibitor IACS-6274 (IPN60090) in patients (pts) with molecularly selected advanced solid tumors.
2021
Author Peers
| Author | Oncology | Molecular Biology | PRM | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Yan Moore | 108 | 95 | 85 | 31 | 214 | |
| Erik Munroe | 10 | 211 | ||||
| Silke Siegert | 60 | 6 | 515 | |||
| Jonathan Guillemette | 10 | 10 | 693 | |||
| Daryl McKee | 26 | 2.7k | ||||
| J. DeFranza | 6 | 10 |
All Works
Login with ORCID to disown or claim papers
Loading papers...